Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Bajaj Healthcare
Join Channel
Consolidated Standalone

Bajaj Healthcare

₹305.7 -0.5 | 0.2%

Market Cap ₹844 Cr.

Stock P/E 39.7

P/B 2.6

Current Price ₹305.7

Book Value ₹ 116.6

Face Value 5

52W High ₹511

Dividend Yield 0.33%

52W Low ₹ 245.1

Edit Ratio

Bajaj Healthcare Research see more...

Overview Inc. Year: 1993Industry: Pharmaceuticals & Drugs

Bajaj Healthcare Ltd is an India-based pharmaceutical business enterprise. The Company is engaged inside the production of bulk drugs and pharmaceutical products. The Company's segments include manufacturing of Bulk Drugs, and Formulation and sale of medicines. The Company manufactures and markets Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with attention on Vitamins, Amino Acids, Anti-Convulsants and other Finished Dosage Forms (FDFs) catering to numerous healing segments. The Company's product portfolio includes numerous APIs within the therapeutic classes of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal and Bacteriostatic, Diuretic and Vasodilator, Mineral and Nutritional dietary supplements, Bronchodilater/Anti-asthmatic and Nootropics. Its FDFs include numerous healing segments, which includes Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, Vitamins and its Derivatives and Anti-Hypertensive.

Read More..

Bajaj Healthcare Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Bajaj Healthcare Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 151 168 176 164 195 133 158 130 101 109
Other Income 0 0 0 1 0 0 1 0 1 1
Total Income 151 168 176 164 195 133 159 130 102 109
Total Expenditure 122 137 151 139 161 102 139 108 82 89
Operating Profit 29 31 26 25 35 31 20 22 20 20
Interest 3 3 4 3 4 5 7 9 8 7
Depreciation 4 5 4 4 4 4 7 6 7 7
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 22 23 17 18 27 21 5 7 5 6
Provision for Tax 5 6 -1 4 6 4 1 -0 0 1
Profit After Tax 17 17 17 14 21 17 4 7 5 6
Adjustments -0 0 -0 -2 -5 -6 0 -55 -9 -8
Profit After Adjustments 17 17 17 12 16 11 4 -48 -3 -2
Adjusted Earnings Per Share 6.3 6.3 6.3 5.2 7.7 6.1 1.3 2.5 1.9 2

Bajaj Healthcare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 157 186 197 200 207 290 325 410 657 680 673 498
Other Income 0 0 0 0 2 2 1 7 7 1 2 3
Total Income 157 186 197 201 210 292 326 417 664 681 675 500
Total Expenditure 144 166 168 170 176 250 282 362 521 561 566 418
Operating Profit 13 20 29 30 33 41 44 55 143 120 109 82
Interest 6 7 8 8 8 8 8 7 8 13 23 31
Depreciation 8 9 9 9 11 11 11 12 16 18 27 27
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -2 3 12 13 14 23 24 36 119 90 58 23
Provision for Tax -0 1 5 5 6 7 8 11 36 18 15 2
Profit After Tax -1 2 8 8 8 15 16 25 83 71 43 22
Adjustments 0 0 0 0 0 0 0 0 0 0 0 -72
Profit After Adjustments -1 2 8 8 8 15 16 25 83 71 43 -49
Adjusted Earnings Per Share 0 0 0 0 2.8 5.5 5.9 9.1 30.1 25.9 15.6 7.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -1% 18% 18% 16%
Operating Profit CAGR -9% 26% 22% 24%
PAT CAGR -39% 20% 23% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -6% -1% 27% NA%
ROE Average 12% 25% 23% 17%
ROCE Average 12% 23% 21% 18%

Bajaj Healthcare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 29 31 82 89 99 114 129 178 258 328 368
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 17 15 22 31 27 21 17 24 80 66 94
Other Non-Current Liabilities -1 -0 0 1 1 2 3 4 5 4 4
Total Current Liabilities 85 99 85 88 93 131 117 138 183 322 436
Total Liabilities 130 145 189 209 219 268 267 343 526 721 901
Fixed Assets 54 56 108 130 128 127 128 162 208 270 366
Other Non-Current Assets 5 3 1 1 0 2 1 12 59 53 26
Total Current Assets 71 86 79 78 91 140 137 168 258 398 510
Total Assets 130 145 189 209 219 268 267 343 526 721 901

Bajaj Healthcare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 0 1 1 0 1 8 8 4 14 2
Cash Flow from Operating Activities 15 17 28 25 22 17 25 21 44 1 -22
Cash Flow from Investing Activities -8 -9 -17 -31 -8 -12 -13 -28 -109 -75 -93
Cash Flow from Financing Activities -7 -8 -11 5 -13 2 -13 3 75 62 131
Net Cash Inflow / Outflow -0 1 -0 -0 0 7 -0 -4 10 -12 16
Closing Cash & Cash Equivalent 0 1 1 0 1 8 8 4 14 2 18

Bajaj Healthcare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0 0 0 0 2.84 5.5 5.91 9.14 30.11 25.87 15.59
CEPS(Rs) 2.61 4.09 6.06 6.48 6.95 9.52 10.04 13.54 35.96 32.26 25.5
DPS(Rs) 0 0 0 0 0 0.5 0 0 1.38 1.5 1
Book NAV/Share(Rs) 0 0 0 0 35.87 26.37 32.21 64.47 93.63 119.02 133.23
Core EBITDA Margin(%) 7.53 9.55 13.2 13.48 13.37 12.06 11.6 11.78 20.76 17.45 15.89
EBIT Margin(%) 2.85 5.23 9.18 9.49 9.49 9.3 8.78 10.41 19.35 15.07 12.06
Pre Tax Margin(%) -0.9 1.61 5.5 6.06 5.94 6.93 6.53 8.79 18.09 13.19 8.65
PAT Margin (%) -0.62 1.03 3.44 3.68 3.39 4.64 4.41 6.16 12.65 10.5 6.39
Cash Profit Margin (%) 4.13 5.39 7.5 7.85 8.31 8.03 7.49 9.11 15.1 13.09 10.45
ROA(%) -0.84 1.53 4.5 4.12 3.65 6.23 6.1 8.28 19.14 11.45 5.3
ROE(%) -3.74 7.31 22.38 19.6 10.77 17.68 20.18 18.92 38.09 24.33 12.36
ROCE(%) 5.11 10.67 19.16 18 14.52 18.25 19.75 19.47 35.91 20 11.88
Receivable days 84.76 88.49 88.85 77.37 75.67 74.24 78.15 78.61 54.82 76.07 111.65
Inventory Days 36.42 35.14 34.51 30.89 28.8 28.13 31.41 30.86 37.89 68.82 99.76
Payable days 70.28 80.76 87.78 67.24 57.47 63.91 68.01 60.64 61.06 78.13 86.83
PER(x) 0 0 0 0 28.66 18.17 17.98 11.24 7.83 13.16 19.55
Price/Book(x) 0 0 0 0 2.27 3.79 3.3 1.59 2.52 2.86 2.29
Dividend Yield(%) 0 0 0 0 0 0.25 0 0 0.58 0.44 0.33
EV/Net Sales(x) 0.47 0.39 0.36 0.44 1.44 1.22 1.13 0.9 1.24 1.76 1.84
EV/Core EBITDA(x) 5.69 3.72 2.47 2.88 8.98 8.54 8.34 6.76 5.7 9.94 11.4
Net Sales Growth(%) 20.35 18.53 6.21 1.51 3.5 39.7 12.27 26.15 60.24 3.49 -0.97
EBIT Growth(%) -18.23 120.28 86.82 5.51 3.55 38.97 6.8 31.41 197.86 -19.42 -20.75
PAT Growth(%) -397.17 299.15 257.27 9.16 -4.58 94.08 7.4 54.73 229.32 -14.11 -39.73
EPS Growth(%) 0 0 0 0 -6.65 94.08 7.4 54.73 229.32 -14.11 -39.73
Debt/Equity(x) 2.4 2.25 1.77 1.75 0.76 1.19 0.91 0.51 0.7 0.78 1.13
Current Ratio(x) 0.84 0.87 0.93 0.89 0.98 1.06 1.17 1.22 1.41 1.24 1.17
Quick Ratio(x) 0.65 0.63 0.72 0.66 0.8 0.81 0.91 0.94 0.88 0.74 0.69
Interest Cover(x) 0.76 1.44 2.5 2.77 2.67 3.93 3.91 6.44 15.25 8.02 3.53
Total Debt/Mcap(x) 0 0 0 0 0.33 0.31 0.28 0.32 0.28 0.27 0.49

Bajaj Healthcare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 67.26 67.26 67.3 67.3 67.42 67.49 67.49 67.69 67.73 67.73
FII 0.32 0.38 0.32 0.09 0.94 0.78 0.69 0.66 0.74 0.53
DII 0 0 0 0 0.34 0.34 0.34 0.44 0.48 0.44
Public 32.42 32.36 32.38 32.61 31.3 31.39 31.48 31.22 31.06 31.3
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 23% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%

Cons

  • Debtor days have increased from 78.13 to 86.83days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Bajaj Healthcare News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!